Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards - Jun 15, 2020

FreeStyle Libre 2 Continuous Glucose Monitor

CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review - Pemberton - 2023 - Diabetes, Obesity and Metabolism - Wiley Online Library

CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review - Pemberton - 2023 - Diabetes, Obesity and Metabolism - Wiley Online Library

The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019

FDA Approves FreeStyle Libre 2 iCGM System for Patients With Diabetes

Abbott Releases the FreeStyle Libre 2 iCGM - Children with Diabetes

Continuous glucose monitoring systems - Current status and future perspectives of the flagship technologies in biosensor research - - ScienceDirect

2 Million Patients And Beyond: Abbott's FreeStyle Libre 2 Cleared In The U.S. For Adults And Children With Diabetes

FreeStyle Libre 14-Day Flash Glucose Replacement Sensor — Mountainside Medical Equipment

FreeStyle Libre 2 System

Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increased HbA1c and weight in well‐controlled youth with type 1 diabetes - Charleer - 2020 - Pediatric Diabetes - Wiley Online Library